Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein A1 pseudogene 59 (HNRNPA1P59) is a human processed pseudogene related by sequence to the HNRNPA1 gene, which encodes a major RNA-binding protein involved in RNA processing. HNRNPA1P59 does not encode a functional protein due to accumulated mutations, and there are no known physiological roles or disease associations assigned to this pseudogene. Like other pseudogenes, it could theoretically have regulatory activity at the RNA level (e.g., as a competing endogenous RNA), but no functional data are available for this specific pseudogene. It should not be considered a conventional drug target or therapeutic receptor. HNRNPA1P59 is not a protein, receptor, or enzyme; it is not a therapeutic target or disease biomarker; and there is no evidence supporting its utility in drug discovery or clinical settings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 59 (HNRNPA1P59).